The global Radiopharmaceuticals market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Radiopharmaceuticals volume and value at global level, regional level and company level. From a global perspective, this report represents overall Radiopharmaceuticals market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Radiopharmaceuticals in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Radiopharmaceuticals manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Scope of the Report:
In the last several years, global market of Radiopharmaceuticals developed year by year, with an average growth rate of 8.02% for the sales. In 2016, global revenue of Radiopharmaceuticals is nearly 4546 M USD; the sale is about 130 M Dose.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The proportion of Diagnostic Radioisotopes in 2016 is about 89.22%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 62.63%.
The worldwide market for Radiopharmaceuticals is expected to grow at a CAGR of roughly 7.8% over the next five years, will reach 7130 million US$ in 2025, from 4900 million US$ in 2019, according to a new Research study.
This report focuses on the Radiopharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Get a FREE sample Copy of this report : https://www.1marketresearch.com/market-reports/radiopharmaceuticals-market-industry-report-102729#requestSample
Market Segment by Manufacturers, this report covers
China Isotope & Radiation
Advanced Accelerator Applications
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Radiopharmaceuticals, with price, sales, revenue and global market share of Radiopharmaceuticals in 2017 and 2018.
Chapter 3, the Radiopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2019 to 2025.
Chapter 13, 14 and 15, to describe Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Jennifer Cantelli was born and raised in the busy city of Lancaster. As a journalist, Jennifer has contributed to many online publications including the The Crimson White and USA Today. In regards to academics, Jennifer earned a degree in business from Carnegie Mellon University and an master’s degree from Temple University. Jennifer follows the money and covers all aspects of state and federal economy.here at Times Records.